Allena Pharmaceuticals Inc EV/EBIT
Quel est le EV/EBIT de Allena Pharmaceuticals Inc?
Le EV/EBIT de Allena Pharmaceuticals Inc est N/A
Quelle est la définition de EV/EBIT?
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
EV/EBIT des entreprises dans Health Care secteur sur NASDAQ par rapport à Allena Pharmaceuticals Inc
Entreprises avec ev/ebit similaire à Allena Pharmaceuticals Inc
- Hi Crush Inc a EV/EBIT de N/A
- Cocrystal Pharma Inc a EV/EBIT de N/A
- Panorama Capital a EV/EBIT de N/A
- Nuverra Environmental Solutions Inc a EV/EBIT de N/A
- Touchpoint a EV/EBIT de N/A
- Equity Metals a EV/EBIT de N/A
- Allena Pharmaceuticals Inc a EV/EBIT de N/A
- Queen's Road Capital Investment a EV/EBIT de N/A
- Uxin Ltd a EV/EBIT de N/A
- Red Light Holland a EV/EBIT de N/A
- St. James Gold a EV/EBIT de N/A
- Eat Beyond Global a EV/EBIT de N/A
- Consolidated Firstfund Capital a EV/EBIT de N/A